Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


J. Nutr. (October 28, 2009). doi:10.3945/jn.109.111567
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow Online Supplemental Material
Right arrow All Versions of this Article:
139/12/2380    most recent
jn.109.111567v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Saraswathi, V.
Right arrow Articles by Hasty, A. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saraswathi, V.
Right arrow Articles by Hasty, A. H.
© 2009 American Society for Nutrition


Nutrition and Disease

Dietary Fish Oil Exerts Hypolipidemic Effects in Lean and Insulin Sensitizing Effects in Obese LDLR–/– Mice1,2,3

Viswanathan Saraswathi4, Jason D. Morrow5,{dagger} and Alyssa H. Hasty4,*

4 Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee 37232 5 Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232

Obesity is often associated with dyslipidemia, insulin resistance, and hypertension. Together, these metabolic perturbations greatly increase the risk of developing cardiovascular disease and diabetes. Although fish oil is a well-established hypolipidemic agent, the mechanisms by which it mediates its lipid-lowering effects are not clear. In addition, it has not been established whether dietary fish oil has different effects in lean and obese mice. LDL receptor deficient (LDLR–/–) and leptin deficient mice on a LDLR–/– background (ob/ob;LDLR–/–) were fed a high fat diet (39% total fat) supplemented with 6% olive oil or fish oil for 6 wk. Fish oil supplementation resulted in lower concentrations of plasma total cholesterol (P < 0.01), triglycerides (P < 0.01), and free fatty acids (P < 0.001) in lean LDLR–/– mice, but not in ob/ob;LDLR–/– mice. In contrast, a fish oil diet did not modulate insulin sensitivity in lean LDLR–/– mice, but it improved insulin sensitivity in ob/ob;LDLR–/– mice (P < 0.05) compared with olive oil fed ob/ob;LDLR–/– mice. Interestingly, plasma adiponectin concentrations were significantly higher and hepatic steatosis was reduced in both mouse models upon fish oil feeding. Finally, fish oil fed LDLR–/– mice exhibited higher hepatic AMP activated protein kinase (AMPK) phosphorylation (P < 0.05), whereas AMPK phosphorylation was not elevated by fish oil feeding in ob/ob;LDLR–/– mice. Taken together, our data suggest that fish oil reduces hepatic steatosis in both lean and obese mice, has potent plasma lipid lowering effects in lean mice, and exerts insulin sensitizing effects in obese mice.


* To whom correspondence should be addressed. E-mail: alyssa.hasty{at}vanderbilt.edu.

Manuscript received 12 June 2009. Initial review completed 17 July 2009. Revision accepted 15 October 2009.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2009 by American Society for Nutrition